Skip to main content

2 Result(s)

within Article Remove this filter Melissa Pavilack Remove this filter Pharmacology/Toxicology Remove this filter

and

  1. Article

    Open Access

    Adverse event rates and economic burden associated with purine nucleoside analogs in patients with hairy cell leukemia: a US population-retrospective claims analysis

    Purine nucleoside analogs (PNAs) are the recommended first-line treatment for patients with hairy cell leukemia (HCL), but they are associated with adverse events (AEs). Due to a lack of real-world evidence re...

    Narendranath Epperla, Melissa Pavilack… in Orphanet Journal of Rare Diseases (2020)

    Download PDF (1079 KB) View Article

  2. No Access

    Article

    Observational Study of Treatment Patterns in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Non-Small Cell Lung Cancer After First-Line EGFR-Tyrosine Kinase Inhibitors

    Epidermal growth factor receptor (EGFR) mutations are observed in approximately 15% of patients with non-small cell lung cancer (NSCLC) in the USA. Little is known about treatment patterns in EGFR mutation-pos...

    Eric Nadler, Melissa Pavilack, Janet L. Espirito, Jamyia Clark… in Advances in Therapy (2020)